Provided by Tiger Fintech (Singapore) Pte. Ltd.

Turnstone Biologics Corp.

0.3618
+0.00170.47%
Post-market: 0.3602-0.0016-0.44%15:11 EDT
Volume:41.59K
Turnover:15.07K
Market Cap:8.37M
PE:-0.13
High:0.3650
Open:0.3620
Low:0.3602
Close:0.3601
Loading ...

Turnstone Biologics Corp. Enters Merger Agreement with XOMA

TIPRANKS
·
28 Jun

BRIEF-Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right

Reuters
·
27 Jun

Turnstone Biologics Corp. Enters Into Agreement to Be Acquired by XOMA Royalty Corporation for $0.34 in Cash per Share Plus a Contingent Value Right

THOMSON REUTERS
·
27 Jun

Turnstone Biologics Corp - Deal Valued at $0.34 per Share Plus CVR

THOMSON REUTERS
·
27 Jun

Turnstone Biologics Q1 EPS $(0.51) Misses $(0.26) Estimate

Benzinga
·
09 May

Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights

THOMSON REUTERS
·
09 May

Turnstone Biologics Q1 EPS USD -0.51

THOMSON REUTERS
·
09 May

Press Release: Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights

Dow Jones
·
09 May

Reported Friday, Turnstone Biologics Q4 2024 GAAP EPS $(0.56) Beats $(0.69) Estimate, Cash $28.9M

Benzinga
·
31 Mar

Turnstone Biologics Q4 Net Income USD -12.872 Million

THOMSON REUTERS
·
29 Mar

Turnstone Biologics Q4 EPS USD -0.56

THOMSON REUTERS
·
29 Mar

Press Release: Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
29 Mar

Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
08 Feb

Piper Sandler Downgrades Turnstone Biologics to Neutral From Overweight, Adjusts Price Target to $0.40 From $3.75

MT Newswires Live
·
05 Feb

Turnstone Biologics downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
05 Feb

Turnstone Biologics Stops Tidal-01 Trials, Explores Strategic Alternatives; Shares Rise

MT Newswires Live
·
04 Feb

Turnstone Biologics Halts TIDAL-01 Studies Amid Market Woes

TIPRANKS
·
04 Feb

Turnstone to discontinue all clinical studies, explore strategic alternatives

TIPRANKS
·
04 Feb

Turnstone Biologics Corp - to Discontinue All Clinical Studies of Tidal-01

THOMSON REUTERS
·
04 Feb

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

THOMSON REUTERS
·
04 Feb